By Rohit Schroff

The popularity of mass spectrometry based testing is growing all the time. As a result, businesses in the diagnostics industry offering mass-spectrometry-based clinical assays, especially analytical laboratories in toxicology environments, are facing a number of major challenges. These include meeting scaling requirements that are non-linear, overcoming regulatory uncertainties while guaranteeing business continuity, raising ROI on LC/MS instruments and lowering turnaround times.

So, if your business is offering mass-spectrometry-based tests, how do you make sure it continues to run smoothly and increase profitability for the long-term? In this short, powerful film, Rohit Shroff, Head of Sales Development, EMEA for the Life Science Markets at Tecan, offers a single, simple answer.

See what Rohit has to say now.

[Attachment]

SUBSCRIBE

Tecan Group AG published this content on 02 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 02 November 2017 19:41:02 UTC.

Original documenthttps://www.tecan.com/blog/growing-a-profitable-diagnostics-business

Public permalinkhttp://www.publicnow.com/view/AFF6246DF725132B45874BE0090CD592E537F6FD